A survey to assess the impact of the COVID-19 pandemic and the resultant lockdown measures on the ongoing clinical trials in India
Perspect Clin Res
.
2021 Jul-Sep;12(3):175-176.
doi: 10.4103/picr.picr_380_20.
Epub 2021 Jul 7.
Authors
Jayanti Gupta
1
,
Rakesh N Dadhania
2
Affiliations
1
Department of Biostatistics, NishKash Consulting, Bengaluru, Karnataka, India.
2
Department of Clinical Research, Quinary Clinical Research, Bengaluru, Karnataka, India.
PMID:
34386384
PMCID:
PMC8323561
DOI:
10.4103/picr.picr_380_20
No abstract available